U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07607119) titled 'PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer' on May 19.
Brief Summary: The purpose of this prospective, single-center, phase II study is to evaluate the clinical efficacy and safety of combining first-line systemic therapy plus immunotherapy with personalized ultrafractionated stereotactic adaptive radiation therapy (PULSAR) in patients with unresectable locally advanced gastric cancer.
Study Start Date: May 15
Study Type: INTERVENTIONAL
Condition:
Gastric Adenocarcinoma
Stomach Neoplasms
Locally Advanced Gastric Cancer
Unresectable Gastric Cancer
Intervention:
RADIATION: PULSAR (Personal...